rozanolixizumab-noli (Rystiggo)

Indications

• generalized myasthenia gravis in adults who are anti-acetylcholine receptor or anti-muscle-specific tyrosine kinase antibody positive

Dosage

• subcutaneous infusion

More general terms

• pharmaceutical monoclonal antibody
• neurologic agent